Medical and Pharmaceutical Edgewise Therapetics shares skyrocket on positive clinical trial returns The company stock rose 55 per cent after results of one dose show immediate results Joseph MortonSeptember 19, 2024
Medical and Pharmaceutical New drug could open personalized treatment strategies for prostate cancer Screening men for BCL2 could allow for the development of personalized treatment plans Joseph MortonSeptember 17, 2024